Skip to content
How It Works15 min readStandard

How Long Does a Ketamine Tablet Stay in Your System?

Oral ketamine tablets are processed differently than IV. See detection windows by test type and what affects how long they stay in your system.

Ketamine Tablet Editorial Team··Reviewed by Ketamine Tablet Editorial Review

Editorial review

Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.

Why the Oral Route Changes the Timeline

If you are asking how long a ketamine tablet stays in your system, you will quickly find that most search results draw on intravenous or intramuscular data rather than oral dosing. That distinction matters: the oral route involves first-pass liver metabolism that fundamentally changes the absorption and clearance picture, and it is worth understanding before thinking about dose scheduling, drug testing situations, or interactions with other medications.

Oral ketamine is a Schedule III controlled substance under the Drug Enforcement Administration's scheduling framework, the same classification as buprenorphine. It is prescribed off-label by licensed clinicians for conditions such as treatment-resistant depression and certain chronic pain syndromes. Because there is no FDA-approved oral ketamine tablet product, dosing, compounding, and monitoring protocols vary by prescriber and pharmacy.

This article focuses specifically on what happens after you swallow a ketamine tablet: how your body processes it, how long it remains detectable by different tests, and what questions are worth raising with your clinician.

What Happens After You Swallow an Oral Ketamine Tablet

When you swallow a ketamine tablet, the drug is absorbed through the gastrointestinal tract and travels to the liver before it reaches your bloodstream, a process called first-pass metabolism. This step significantly reduces the amount of active ketamine that enters circulation. Published pharmacology research estimates oral bioavailability at roughly 17-29%, compared to nearly 100% for intravenous administration. For a detailed explanation of what this means for tablets, see our guide on bioavailability and oral ketamine.

The liver converts ketamine primarily into norketamine, a pharmacologically active metabolite, and then into dehydronorketamine, which is largely inactive. Both compounds are excreted mainly through urine, published research suggests approximately 90% of ketamine metabolites leave the body via the kidneys. Understanding this two-stage conversion is important because norketamine has its own pharmacological activity and its own clearance timeline, one that extends beyond when you feel the effects of your dose.

Compare tablet options

Review tablets versus troches, IV infusion, and other routes before deciding what to ask.

Compare options

The Elimination Half-Life of Oral Ketamine

The elimination half-life of ketamine, the time for its blood concentration to fall by half, is generally reported at approximately 2 to 3 hours across routes of administration, based on published pharmacokinetic data available through peer-reviewed research indexed on PubMed. At that rate, most of the parent ketamine compound clears from the bloodstream within roughly 10 to 15 hours of a dose.

For oral tablets specifically, absorption is slower than IV delivery. Plasma levels typically rise over 20 to 45 minutes after swallowing a tablet, then decline along the usual metabolic pathway. Blood levels of the drug itself may fall below detection within 1 to 3 days, but urine detection extends further because metabolites accumulate in the renal system and are excreted gradually.

One important caveat: most published half-life estimates come from anesthetic or high-dose IV studies. Data specific to the lower doses used in outpatient oral ketamine prescriptions are more limited, so your clinician is the most reliable guide for how these numbers apply to your situation. For more on how concentration builds and falls after a tablet dose, see our page on peak plasma levels of ketamine tablet.

Detection Windows by Test Type

FeatureApproximate Detection WindowPractical Notes for Tablet Users
Blood1-3 daysCaptures both the active drug and norketamine. The window is shorter because the bloodstream clears more rapidly than urine. Most commonly used in clinical or emergency settings.
Urine3-14 days for occasional use; potentially longer with repeated dosingThe most commonly used test for drug screening. Metabolites concentrate in urine and persist after the drug itself clears from blood. Higher doses and more frequent use extend the window.
Saliva1-3 daysLess commonly used in clinical or employment contexts. Reflects recent use but generally shows a shorter window than urine because it mirrors blood levels more closely.
Hair follicleUp to approximately 90 daysMetabolites are incorporated into the hair shaft as it grows, typically becoming detectable 7-10 days after use. Rarely used for therapeutic monitoring but may appear in legal or forensic contexts.

Individual Factors That Affect How Long Ketamine Stays in Your System

Dose and Frequency

Higher doses and more frequent use create a larger metabolite load. Someone taking oral ketamine on a regular schedule may accumulate norketamine more than an occasional user, extending the urine detection window.

Liver Function

Ketamine is processed primarily in the liver. Conditions that reduce liver function, such as hepatitis, cirrhosis, or certain medications, can slow metabolite conversion and delay overall clearance.

Kidney Function

Most metabolites exit through urine, so reduced kidney function can slow excretion and extend how long metabolites remain detectable regardless of how quickly the liver processes the drug.

Age and Metabolic Rate

Metabolic processing tends to change with age. Older adults may clear ketamine more slowly than younger adults, though individual variation is considerable within any age group.

Body Composition

Ketamine is lipophilic, it distributes into fatty tissue. A larger distribution volume can affect the drug's redistribution and, to some extent, the overall elimination timeline.

Concurrent Medications

Drugs that inhibit or induce CYP3A4 liver enzymes, including some antifungals, antibiotics, and anticonvulsants, can alter how quickly your liver processes ketamine. Always review all medications with your prescriber.

Norketamine: Why the Active Metabolite Matters for Detection

After your liver converts ketamine into norketamine, that metabolite remains pharmacologically active, meaning it can contribute to both therapeutic effects and side effects after the parent drug has largely left your bloodstream. Drug tests that are sensitive to ketamine will typically also detect norketamine, and because norketamine follows its own clearance timeline, it extends the detectable window beyond when ketamine itself is measurable.

In practical terms: you may feel the subjective effects of an oral tablet wear off within 1 to 2 hours of your dose, but norketamine and dehydronorketamine can remain present in urine for days afterward. The gap between how you feel and what a test would show is an important distinction for anyone dealing with drug screening situations.

If your prescriber monitors your response over time, norketamine levels may be part of that picture. For more on how clinicians track therapeutic response, see our guide on monitoring your response to ketamine tablet.

Practical Timing Considerations for Tablet Users

Two categories of timing questions come up often for people prescribed oral ketamine tablets: when it is safe to resume activities like driving, and whether the drug will appear on a screening test.

Driving and operating machinery: The dissociative and sedating effects of oral ketamine typically resolve within 1 to 2 hours of a dose, though individual response varies and some residual cognitive effects may persist beyond that window. Your prescriber should give you specific guidance based on your dose and how you have responded. For more context, see our article on driving after an oral ketamine dose.

Drug screening situations: Standard workplace urine drug panels do not always include ketamine, but expanded or targeted panels can detect it. If you are subject to workplace, military, legal, or insurance testing, the appropriate step is to disclose your prescription to the testing administrator, a valid patient-provider relationship is a documented basis for therapeutic use. Timing your dose around clearance estimates is not an appropriate strategy, and what counts as proper disclosure in your specific context is a question for your prescriber and, if needed, a legal professional.

Dosing intervals: Clearance data does not determine when your next dose should occur. Your prescribing clinician set your schedule based on efficacy and safety, not on elimination windows alone. Do not adjust your dosing timing based on clearance estimates.

Detection windows reflect population averages, not individual predictions

The detection windows in this article are based on published research across populations and test types. A specific test result on a given day depends on that test's sensitivity threshold, your metabolic profile, your dosing history, and other variables no general table can capture. If you have a specific testing situation, medical, legal, or employment-related, discuss it with your prescriber and review our editorial disclaimer before drawing personal conclusions from these ranges.

Questions to Work Through With Your Prescribing Clinician

1

Ask how norketamine factors into your care

Find out whether your clinician monitors norketamine levels specifically and what role this active metabolite plays in your therapeutic response or any side effects you have noticed.

2

Disclose any testing requirements upfront

If you are subject to workplace, military, legal, or insurance drug testing, tell your prescriber so they can document the therapeutic relationship appropriately and advise you on disclosure procedures before any test occurs.

3

Review all concurrent medications

Ask whether any other drugs you take, including over-the-counter products and supplements, could interact with CYP3A4 liver enzymes in a way that slows or accelerates ketamine metabolism.

4

Understand your organ function baseline

If you have known liver or kidney impairment, ask how that affects your expected clearance timeline and whether your prescribed dose already accounts for that reduced capacity.

5

Get specific guidance on driving and activities

Request a concrete instruction, not just a general rule, about how long after your prescribed dose you should wait before driving, operating machinery, or returning to cognitively demanding work.

How Oral Tablets Compare to Other Routes on Clearance

Most published clearance data on ketamine come from IV or intramuscular studies, often using anesthetic doses that are much higher than those in outpatient oral prescriptions. Two characteristics of the oral route make direct comparison tricky.

First, because oral bioavailability is roughly 17-29%, peak plasma concentrations after a tablet are substantially lower than after an equivalent IV infusion. The absolute quantity of drug your liver and kidneys process is lower, though the metabolic pathway and urine excretion mechanics are the same.

Second, oral absorption is gradual rather than immediate. The concentration curve rises slowly and falls slowly, compared to the sharp peak and rapid redistribution seen with IV ketamine. The tail end of oral exposure is more spread out, even if total clearance time follows a similar arc overall.

If you have read articles stating that ketamine leaves the body within hours, those accounts typically describe the IV anesthetic context, specifically, the resolution of acute anesthetic effects through redistribution, not the clearance of urine metabolites. For oral tablet users, urine detection can extend days beyond that point. For a grounded look at how oral ketamine performs therapeutically, see our overview of oral ketamine safety and efficacy: the evidence.

How Food and Stomach Contents Affect the Timeline

Taking an oral ketamine tablet with food can slow gastric emptying and alter the absorption curve, delaying the time to peak plasma concentration and potentially reducing peak levels compared to a fasted state. Research on oral ketamine suggests that a fed state changes the pharmacokinetic profile in ways that may affect both onset and the overall experience of a session. For a thorough look at this interaction, see our guide on how food affects ketamine tablet absorption.

From a clearance perspective, food does not meaningfully change the total amount of drug that eventually enters and leaves your body, only the timing of absorption. Follow your prescriber's instructions about food and dosing rather than adjusting based on pharmacokinetic theory. For a fuller picture of how the tablet experience unfolds from dose to resolution, see our article on onset and duration of ketamine tablet.

Frequently Asked Questions

Research on ketamine clearance generally suggests the drug and its main metabolite, norketamine, can be detected in urine for approximately 3 to 14 days after occasional use, with the window potentially extending further for people who take it regularly or at higher doses. These figures are drawn from studies across routes of administration; published data specific to low-dose oral tablet prescriptions are more limited. Your actual window depends on dose, dosing frequency, kidney function, hydration, and other individual factors. Discuss your specific situation with your prescriber rather than relying solely on population-average estimates.

Many standard workplace urine drug panels do not specifically test for ketamine. However, expanded panels and targeted screens can detect it. If you have a valid prescription and anticipate testing, the appropriate step is to disclose your prescription to the testing administrator, not to time your dose around estimated clearance windows. Your prescriber can help document the therapeutic relationship for that purpose.

The elimination half-life of ketamine, approximately 2 to 3 hours, is similar across routes. Because oral bioavailability is lower (roughly 17-29%), peak plasma concentrations from a tablet are substantially lower than from an equivalent IV infusion, so the total drug load your body processes is smaller. The metabolic pathway and urine excretion timeline are similar regardless of route, but oral tablet users are typically working with lower total drug exposure than IV patients.

The dissociative and sedating effects of oral ketamine typically resolve within 1 to 2 hours of a dose, but residual effects on cognition and coordination may persist beyond that window. Your prescribing clinician should provide specific guidance based on your dose and individual response, do not make driving decisions based solely on how you feel or on general clearance estimates. See our detailed article on driving after an oral ketamine dose for more context.

There is no established method to reliably accelerate ketamine clearance. Adequate hydration supports normal kidney function, which is part of the metabolite excretion process, but drinking excess water does not meaningfully shorten detection windows and carries its own risks. The most useful approach is to understand your personal clearance factors, liver function, kidney function, concurrent medications, and discuss them with your prescriber rather than attempting to intervene in the clearance process.

Norketamine is the primary active metabolite your liver produces when breaking down ketamine. It remains pharmacologically active and can contribute to both therapeutic effects and side effects. Drug tests sensitive to ketamine will typically also detect norketamine, and because norketamine has its own elimination half-life, it extends the detectable window after the parent drug has largely cleared. This is why the subjective effects of a tablet may resolve hours before a urine test would return a negative result.

Yes. Hair follicle tests can detect drug metabolites for up to approximately 90 days, reflecting their incorporation into the hair shaft as it grows. A single oral dose would typically become detectable in a hair sample within 7 to 10 days of use. Hair testing is rarely used for therapeutic monitoring of prescribed ketamine but may appear in forensic, legal, or certain employment contexts. If hair testing is a concern for your situation, raise it with your prescriber and, where appropriate, with a legal professional.

With an elimination half-life of roughly 2 to 3 hours, ketamine itself does not substantially accumulate between doses taken on a typical once-daily or less frequent schedule. However, norketamine has a longer half-life and may accumulate to some degree with frequent dosing. Your prescriber's recommended interval accounts for this. Do not adjust your dosing frequency based on clearance estimates without first consulting your clinician.

Keep Learning About Oral Ketamine Tablets

Clearance is one piece of understanding how oral ketamine tablets work. Explore related guides on absorption, peak plasma levels, and session planning before making treatment decisions.

Share

Contact Ketamine Tablet

Send corrections, provider questions, or advertising inquiries.

Contact the site